Study Finds Evidence of Gender-Related Differences In Development of Colon Cancer

	Tweet

A new study by researchers at the University of Southern California (USC) has found evidence that supports gender-related differences in the development and survival of metastatic colon cancer.

The study, which will be published in the April 15 issue of the journal Cancer Research, found that specific gene variants linked to the development of colon cancer resulted in opposite survival outcomes for men and women.

Germline variations in the epidermal growth factor receptor (EGFR) DNA —a gene widely expressed in colonic tissue—has been linked with poor prognosis in colon cancer, says Oliver Press, an M.D. student at the Keck School of Medicine of USC and lead author of the study. However, when researchers looked at EGFR as a prognostic factor, they found that it had opposite implications for men and women. 

“We expected to find that high expression would correlate with a poor prognosis and faster growth of the cancer,” says Press. “What we found was that men followed the expected trend, while women’s response was the opposite.”

Researchers analyzed 318 patients—177 men and 141 women—with metastatic colon cancer treated at the USC/Norris Comprehensive Cancer Center and the LAC+USC Medical Center between 1992 and 2003. All the patients were exposed to similar chemotherapy treatments. When genomic DNA samples were analyzed, researchers found that women who had specific gene variants linked with high expression of EGFR had higher overall survival rates, while men with the same variants had lower survival.

“This is the first report to show that the prognostic value of EGFR depends on gender,” says Heinz-Josef Lenz, M.D., professor of medicine at the Keck School of Medicine and the principal investigator on the study. “This may suggest that, in the future, molecular markers should be evaluated differently in women and men and that treatment decisions may depend on gender and not only on molecular or clinical findings.”

Previous research has shown a protective effect of female hormones in colon cancer survival, Press notes. The findings of the study indicate that hormone receptors are important to signal pathways related to the survival of patients.

The study is an important jumping off point to further research into how men and women differ in response to specific treatments, he says.

“Research will need to be done to determine whether women and men respond differently to certain cancer therapies,” Press says. “Down the road we may see targeted chemotherapy that is tailored to get the best response from male and female patients.”

The study was supported by grants from the National Institutes of Health,
the San Pedro Guild Research Fund and Charles Bittick.

Oliver A. Press, Wu Zhang, Michael A. Gordon, Dongyun Yang, Georg Lurje, Syma Iqbal, Anthony El-Knoueiry and Heinz-Josef Lenz., “Gender-Related Survival Differences Associated with Epidermal Growth Factor Receptor Polymorphisms in Metastatic Colon Cancer.” Cancer Research, April 15, 2008. Doi:10.1158/0008-5472.CAN-07-2718.

Source: University of Southern California Health Sciences

RELATED STORIES:
Diet, smoking, exercise key in colon cancer risk   Lack of sleep linked to risky colon polyps   Obesity hurts recovery after colon cancer surgery   Daily drinking may raise risk of several cancers   Study reveals differences in cancer stage presentation between rural and urban patients   What’s Stopping You? Colorectal Screenings Can Prevent Cancer   Apple pectin, apple juice extracts shown to have anticarcinogenic effects on colon   Chemoradiation for adenocarcinoma of the anus   Colorectal Cancer Screening Rates Still Too Low   Lack of sleep found to be a new risk factor for colon cancer   US cancer deaths down but far too few Americans screened for colon cancer   Statin drugs may lower colon cancer risk - study   Hydrophobic proteins: Potential biomarkers for colorectal cancer   Morbidly obese patients face high risk for complications after colectomy   Post-Treatment Diet Patterns Explored in Colorectal Cancer Patients   Calcium Associated With Lower Risk of Cancer in Women   Study Sets Treatment Standard for Elderly with Colon Cancer   Many colon cancer patients skip follow-up care   Shifting a Paradigm: a Molecular Approach to Staging Colorectal Cancer   City of Hope researchers to present rectal cancer, palliative care, benchmarking studies at ASCO   Metabolic syndrome ups colorectal cancer risk   Colon cancer and the microbes in your gut

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]